1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services, including organ transportation through its fleet of 18 aircraft. » Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read More
Will Shiba Inu Hit $1?
It’s no mean feat for a token to rise to public notoriety given that tens of thousands of them currently exist. But Shiba Inu is that rare token that captured the public’s attention, at least for a while. Trading now at $0.00001097, the question looms: Will Shiba Inu hit $1?
Meme Token Bubble
At its peak in October 2021,
» Read more about: Will Shiba Inu Hit $1? »
Read More
5 Buffett Stocks On Sale
Today, we wanted to share something different: 5 top stocks on sale in Warren Buffett’s portfolio. The benchmark for determining valuation was a discounted cash flow forecast analysis. So, without further ado, let’s kick off with Occidental Petroleum, which has garnered a lot of attention over the past twelve months.
Occidental Petroleum
Not only does OXY have 29.3% upside to fair value based on our calculations but it’s also a significant holding for Buffett.
» Read more about: 5 Buffett Stocks On Sale »
Read More
$2 Billion Fund Bets It All On 5 Stocks
You probably haven’t heard of Himalaya Capital Management. It’s a Seattle, Washington-based firm that has approximately $2 billion in assets under management. Now put yourself in the shoes of the investment team for a moment: how would you invest that chunk of change?
Most investors would spread the money around a bit but the Himalaya team has chosen to embrace the philosophy that if you have conviction in your investment themes,
» Read more about: $2 Billion Fund Bets It All On 5 Stocks »
Read More
Is Tesla In Nose-Bleed Territory?
Tesla has had a scintillating run since Election Day with the stock rallying from the low $220 region all the way towards $350+ in a matter of days.
Having run so far so fast, what are the odds Tesla share price is set to correct soon? How high is too high for Tesla stock price?
» Read more about: Is Tesla In Nose-Bleed Territory? »
Read MoreThe Ivy
AI Bets and Buffett’s Seal of Approval, Is This a Bet on a Cashless Future?
There is something inherently attractive about buying a stock and holding it for a long time. Stable don’t just have strong balance sheets that can weather rough markets but they often pay dividends, which account for as much as 95% of total returns over the past century according to research by Wharton Professor Jeremy Siegel.
» Read more about: AI Bets and Buffett’s Seal of Approval, Is This a Bet on a Cashless Future? »
Read MoreThe Spotlight
Is This Space Firm Set To Blast Off
At an annual conference some years ago, a Berkshire Hathaway shareholder asked Warren Buffett how it was possible for smaller investors to rival his own performance and track record during the 1960s, which was his best period. He corrected the questioner and commented that, in fact, his best years were prior to that in the 1950s when he averaged gains closer to 50% annually.
» Read more about: Is This Space Firm Set To Blast Off »
Read MoreThe Daily
Here’s who qualifies for Social Security payments this week
Millions of Americans will receive their monthly Social Security checks this week, with those receiving the maximum retirement benefit set to bring in more $5,000.
When recipients receive their monthly benefits varies based on their birthdate.
For those with a birthdate between the 1st and the 10th of the month,
» Read more about: Here’s who qualifies for Social Security payments this week »